Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

healthcare business deal

Roche, Ibex Medical Analytics and AWS partner for better cancer diagnostics

The three companies are partnering to bring AI tools to Roche’s digital pathology platform to streamline cancer diagnoses.

Thumbnail

Study finds immediate access to radiology results eases oncology patients' anxiety

The findings show most patients prefer discussing sensitive imaging results with their healthcare provider in a timely manner.

ovaries ovarian cancer

Pretargeted radioimmunotherapy shows early promise in treating aggressive ovarian cancer

The new-look nuclear medicine treatment was able to cure advanced ovarian cancer in some mice, with limited side effects.

Souvik Roy UTA

'Robust' new imaging technique combines ultrasound with optical tomography

Researchers with the University of Texas at Arlington received a grant worth $190,000 to continue working on the new modality. 

Thumbnail

Preop prostate MRI findings predict cancer recurrence at rates similar to pathology, analysis shows

Given the similarities in accuracy between pathology results and preoperative imaging, MRI could have a greater role in risk assessments in the future, experts suggested in AJR.

Thumbnail

SPECT/CT helps personalize treatment options for prostate cancer patients

Using SPECT/CT imaging, providers can stratify patients based on their treatment responses and make personalized adjustments accordingly.

whole-body pet scanner add-on device presented at #SNMMI 2023

New PET technology offers 'clear improvement' of whole-body scan resolution

The new technology achieves this by way of two add-on detectors that simultaneously scan patients during their whole-body PET exam.

Thumbnail

New prostate cancer PET imaging agent officially available for commercial use

Posluma (flotufolastat F 18) received the U.S. Food and Drug Administration’s approval in May 2023.

Around the web

United Imaging and other manufacturers that have established American factories may remain insulated from the trade war.

Erik Rockswold, director research and quality, Rayus Radiology, explains the administrative burdens radiology groups experience for little return from the Merit-Based Incentive Payment System.  

HeartFocus guides users through the entire process, making it so that even novices can deliver high-quality echocardiograms every time.